ANIP News and Press, ANI Pharmaceuticals Inc. From 08/03/20

Effective September 8, ANI Pharmaceuticals (NASDAQ: ANIP ) appoints  Nikhil Lalwani as President and CEO succeeding Patrick D. Walsh More news on: ANI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

-Accomplished leader with proven record of achievement to drive next phase of Company’s growth- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani has been named the Company’s President and Chi...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets. Patrick Walsh, Interim Presi...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

BAUDETTE, Minn. , July 6, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the acquisition of Fluconazole Tablets USP, 50mg, 100mg, 150mg, and 200mg from a private company for $3.0 million .  The current annual U.S. market for this product i...

BAUDETTE, Minn. , June 30, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current annual U.S. market for this product is approximately $16 million , according to IQ...

Ignorance is relatively easy to overcome; stupidity is much harder. "― Marty Rubin Today, we take a look at a stock that has fallen on some hard times as it jettisoned its long-term CEO and faced other short-term challenges. However, with management changes and other potential cata...

It is no secret that prescription drug prices in America are the highest among all developed nations. A variety of factors have contributed to the issue, such as a lack of universal healthcare coverage, the staggering cost of conducting clinical trials to get drugs to approval, and price gougin...

BAUDETTE, Minn. , June 1, 2020 /PRNewswire/ --  ANI Pharmaceuticals, Inc. ("ANI")  (NASDAQ: ANIP) announced today that it continues to make progress toward addressing items identified in the Refusal to File letter received from the FDA relating to its Cortrophin® Gel sNDA f...

ANI Pharmaceuticals, Inc. (ANIP) Q1 2020 Earnings Conference Call May 7, 2020 10:30 A.M. ET Company Participants Arthur Przybyl - Chief Executive Officer Stephen Carey - Chief Financial Officer Patrick Walsh - ANI Board Member Conference Call Participants Presentation ...